Transforming growth factor-β administration modifies cyclosporine A-induced bone loss

This publication has 36 references indexed in Scilit:

• Skeletal Effects of Low-Dose Cyclosporin A in Aged Male Rats: Lack of Relationship to Serum Testosterone Levels
  Journal of Bone and Mineral Research, 1998
• The Role of Testosterone in Cyclosporine-Induced Osteopenia
  Journal of Bone and Mineral Research, 1997
• T lymphocytes play a critical role in the development of cyclosporin A- induced osteopenia
  Endocrinology, 1996
• Post-transplantation bone disease: The role of immunosuppressive agents and the skeleton
  Journal of Bone and Mineral Research, 1996
• Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype.
  The Journal of cell biology, 1996
• Transforming Growth Factor β in Tissue Fibrosis
  New England Journal of Medicine, 1994
• THE DELETERIOUS EFFECTS OF LONG-TERM CYCLOSPORINE A, CYCLOSPORINE G, AND FK506 ON BONE MINERAL METABOLISM IN VIVO
  Transplantation, 1994
• 1,25 dihydroxyvitamin D3 modifies cyclosporine-induced bone loss
  Calcified Tissue International, 1990
• Regression of bone and cartilage loss in adjuvant arthritic rats after treatment with cyclosporin a
  Arthritis & Rheumatism, 1990
• BONE HISTOLOGY IN RENAL TRANSPLANT PATIENTS RECEIVING CYCLOSPORIN
  The Lancet, 1988